NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 9 filers reported holding NOVOZYMES A S DKK 2.0 in Q3 2015. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $291,358 | -29.1% | 4,775 | -32.0% | 0.08% | -28.9% |
Q1 2024 | $410,754 | +2.2% | 7,025 | -4.2% | 0.11% | -10.9% |
Q4 2023 | $402,042 | +4.2% | 7,335 | -23.5% | 0.13% | -2.3% |
Q3 2023 | $385,859 | -36.7% | 9,585 | -26.9% | 0.13% | -32.1% |
Q2 2023 | $609,360 | -10.2% | 13,120 | -1.5% | 0.19% | -14.6% |
Q1 2023 | $678,197 | -21.3% | 13,320 | -22.0% | 0.23% | -27.3% |
Q4 2022 | $861,995 | -9.7% | 17,070 | -9.9% | 0.31% | -14.3% |
Q3 2022 | $955,000 | -34.3% | 18,945 | -22.0% | 0.36% | -29.7% |
Q2 2022 | $1,454,000 | -39.2% | 24,275 | -30.3% | 0.52% | -28.3% |
Q1 2022 | $2,392,000 | -36.4% | 34,825 | -24.1% | 0.72% | -32.2% |
Q4 2021 | $3,761,000 | +1.1% | 45,900 | -15.7% | 1.06% | -9.9% |
Q3 2021 | $3,720,000 | -21.4% | 54,440 | -13.5% | 1.18% | -19.9% |
Q2 2021 | $4,735,000 | -11.4% | 62,960 | -24.7% | 1.47% | -13.5% |
Q1 2021 | $5,342,000 | +6.5% | 83,635 | -4.6% | 1.70% | +3.8% |
Q4 2020 | $5,016,000 | -14.3% | 87,630 | -6.0% | 1.64% | -21.4% |
Q3 2020 | $5,856,000 | +8.1% | 93,200 | -0.8% | 2.08% | +2.9% |
Q2 2020 | $5,416,000 | +23.0% | 93,960 | -2.8% | 2.03% | +4.5% |
Q1 2020 | $4,403,000 | -6.7% | 96,625 | -0.1% | 1.94% | +14.7% |
Q4 2019 | $4,720,000 | +14.4% | 96,705 | -1.8% | 1.69% | +8.7% |
Q3 2019 | $4,127,000 | -10.0% | 98,445 | -0.2% | 1.55% | -8.7% |
Q2 2019 | $4,586,000 | +1.3% | 98,660 | 0.0% | 1.70% | -3.5% |
Q1 2019 | $4,526,000 | +2.8% | 98,660 | -0.2% | 1.76% | -9.8% |
Q4 2018 | $4,401,000 | -20.7% | 98,830 | -2.6% | 1.96% | -6.7% |
Q3 2018 | $5,552,000 | +5.8% | 101,470 | -2.0% | 2.10% | -5.7% |
Q2 2018 | $5,247,000 | -4.0% | 103,570 | -2.3% | 2.22% | -4.6% |
Q1 2018 | $5,466,000 | -10.2% | 106,055 | -0.7% | 2.33% | -7.2% |
Q4 2017 | $6,087,000 | +38.2% | 106,845 | +24.3% | 2.51% | +9.5% |
Q3 2017 | $4,403,000 | +16.3% | 85,985 | -0.6% | 2.29% | +12.1% |
Q2 2017 | $3,787,000 | +13.7% | 86,485 | +2.9% | 2.04% | +10.4% |
Q1 2017 | $3,332,000 | +16.7% | 84,060 | +1.6% | 1.85% | +12.0% |
Q4 2016 | $2,855,000 | -18.4% | 82,770 | +4.1% | 1.65% | -18.1% |
Q3 2016 | $3,497,000 | -5.0% | 79,520 | +4.0% | 2.02% | -16.9% |
Q2 2016 | $3,680,000 | +10.0% | 76,495 | +2.8% | 2.43% | +9.4% |
Q1 2016 | $3,346,000 | -5.5% | 74,445 | +1.2% | 2.22% | -10.2% |
Q4 2015 | $3,541,000 | +11.9% | 73,545 | +1.2% | 2.47% | +10.0% |
Q3 2015 | $3,165,000 | -8.6% | 72,645 | -0.3% | 2.25% | +0.8% |
Q2 2015 | $3,463,000 | +4.3% | 72,845 | +0.4% | 2.23% | +5.2% |
Q1 2015 | $3,321,000 | +9.0% | 72,555 | +0.5% | 2.12% | +6.0% |
Q4 2014 | $3,047,000 | -1.6% | 72,200 | +1.1% | 2.00% | -5.9% |
Q3 2014 | $3,098,000 | -16.2% | 71,405 | -3.1% | 2.13% | -17.1% |
Q2 2014 | $3,696,000 | +15.2% | 73,680 | +1.1% | 2.56% | +11.1% |
Q1 2014 | $3,207,000 | +3.6% | 72,910 | -0.6% | 2.31% | +2.3% |
Q4 2013 | $3,095,000 | +15.9% | 73,330 | +5.1% | 2.26% | +1.1% |
Q3 2013 | $2,670,000 | +20.4% | 69,780 | +0.7% | 2.23% | +14.7% |
Q2 2013 | $2,217,000 | -6.7% | 69,280 | -1.1% | 1.95% | -6.1% |
Q1 2013 | $2,377,000 | +15.3% | 70,080 | -4.4% | 2.07% | +5.3% |
Q4 2012 | $2,062,000 | – | 73,288 | – | 1.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kidder Stephen W | 95,000 | $4,178,000 | 2.81% |
ELEFANTE MICHAEL B | 142,095 | $6,249,000 | 2.70% |
PUZO MICHAEL J | 72,910 | $3,207,000 | 2.31% |
Fayerweather Charles | 14,875 | $654,000 | 2.27% |
Hemenway Trust Co LLC | 149,760 | $6,585,000 | 2.07% |
SOMERVILLE KURT F | 117,965 | $5,187,000 | 2.06% |
Broderick Brian C | 93,546 | $4,113,000 | 2.02% |
Page Arthur B | 33,055 | $1,454,000 | 1.40% |
FIDGEON TIMOTHY F | 62,815 | $2,762,000 | 1.31% |
Notis-McConarty Edward | 33,496 | $1,473,000 | 1.03% |